Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years. Issue 2 (26th August 2021)

Record Type:: Journal Article
Title:: Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years. Issue 2 (26th August 2021)
Main Title:: Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years
Authors:: King, Hayley
Deshpande, Sanjay
Woodbridge, Tamsin
Hilliard, Tom
Standing, Jon
Lewis, Mary
Ward, Lesley
Finn, Adam
Roderick, Marion
Abstract:
Is Part Of:: Archives of disease in childhood. Volume 107:Issue 2(2022)
Journal:: Archives of disease in childhood
Issue:: Volume 107:Issue 2(2022)
Issue Display:: Volume 107, Issue 2 (2022)
Year:: 2022
Volume:: 107
Issue:: 2
Issue Sort Value:: 2022-0107-0002-0000
Page Start:: 205
Page End:: 207
Publication Date:: 2021-08-26
Subjects:: COVID-19 -- adolescent health -- paediatrics -- child health services -- allergy and immunology
Children -- Diseases -- Periodicals
Infants -- Diseases -- Periodicals
618.920005
Journal URLs:: http://adc.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/archdischild-2021-322655 ↗
Languages:: English
ISSNs:: 0003-9888
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23081.xml